(Albany, US) DelveInsight’s “Allergic Rhinoconjunctivitis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Allergic Rhinoconjunctivitis , historical and forecasted epidemiology as well as the Allergic Rhinoconjunctivitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Allergic Rhinoconjunctivitis, which is caused by an allergen, refers to nose and eye problems that occur at least once a week. When only the nose is affected, it is called allergic rhinitis (AR). It is also known as hay fever, “sinus” or “sensitive nose”. When only the eyes are affected, it is called Allergic Rhinoconjunctivitis.

 

Some facts about Allergic Rhinoconjunctivitis Market: 

• The study conducted by Blaiss et al., titled “The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents”, estimates that in a European analysis of population-based studies the estimated prevalence was found to be 15.1–37.8% in adolescents aged 12–15 years, and data from a cross-sectional study in the US estimated an AR prevalence of 24.8% in 14–17 year. It was also observed that prevalence in this age group is increasing.
• According to the study conducted by Langen et al., titled “Prevalence of allergic diseases in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)”, the lifetime prevalence of allergic rhinoconjunctivitis was found to be 14.8%.

• The study by Bielory et al.,(n.d.) titled “Allergic Rhinoconjunctivitis and the Impact of Allergic Rhinitis” estimated that the prevalence of rhinoconjunctivitis symptom was 14.6% among 13–14-year-olds (range, 1–45.1%), and for 6–7 year patients the prevalence was 8.5%, along with a wide geographic variations.

 

Request for Free Sample Report:  https://www.delveinsight.com/report-store/allergic-rhino-conjunctivitis-market

 

Scope of the Allergic Rhinoconjunctivitis Market Report:

• The report covers the descriptive overview of Allergic Rhinoconjunctivitis , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Allergic Rhinoconjunctivitis epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Allergic Rhinoconjunctivitis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Allergic Rhinoconjunctivitis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Allergic Rhinoconjunctivitis market

 

Request for Free Sample Report: https://www.delveinsight.com/report-store/allergic-rhino-conjunctivitis-market

 

Allergic Rhinoconjunctivitis Symptoms & Causes:

Allergic Rhinoconjunctivitis displays common symptoms like watery, itchy, red, and burning eyes. Additionally, a person may also have puffy eyes in the morning when waking up.

The body produces histamine, a potent chemical used for fighting off foreign invaders. When trying to defend itself against a perceived threat, this release of histamine causes a person to experience Allergic Rhinoconjunctivitis. Substances that trigger the reaction include –  mold spores, household dust, animal dander, pollen from grass trees, chemical scents, and certain eye medications.

 

Some of Allergic Rhinoconjunctivitis Companies:

• LOFARMA S.P.A
• Emergo Therapeutics
• FAES Farma
• ALK-Abelló A/S
• And many others

 

Allergic Rhinoconjunctivitis Therapies Covered:

• Bilastine
• LAIS Grass pollen tablets
• Norketotifen
• Itulazax
• And Many Others

 

Table of Contents:

1. Key Insights
2. Executive Summary of Allergic Rhinoconjunctivitis
3. Competitive Intelligence Analysis for Allergic Rhinoconjunctivitis
4. Allergic Rhinoconjunctivitis : Market Overview at a Glance
5. Allergic Rhinoconjunctivitis : Disease Background and Overview
6. Patient Journey
7. Allergic Rhinoconjunctivitis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Allergic Rhinoconjunctivitis Treatment
11. Marketed Products
12. Emerging Therapies
13. Allergic Rhinoconjunctivitis : Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Allergic Rhinoconjunctivitis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

 

Others Reports:

Rituximab Biosimilars Insight

DelveInsight’s, “Rituximab Biosimilar Insight, 2022,” report provides comprehensive insights about 35+ companies and 35+ marketed and pipeline drugs in the Rituximab Biosimilars landscape.

 

About DelveInsight

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/allergic-rhino-conjunctivitis-market